Representative before the EPO

Employment test 51 - 200 employees
Company dna d young and co llp
operating since 1891
Headquarter in London and 2 offices
active in Legal Services, IP Consulting, and IP Portfolio Processing

Representative before the EPO

Company dna bryer shelley john amor greenwood llp
no operation time available
1 office
active in Legal Services

Representative before the EPO

Company dna bryers llp
no operation time available
924.73
1 office
active in Legal Services

Representative before the EPO

Company dna script ip limited
no operation time available
1 office
active in Legal Services

We have observed 12 EP applications William John Richards has served for within the last five+ years. (We consider all applications which have an EP A1 or A2 publication dated after June 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP11826214

BIOMARKERS ASSOCIATED WITH PRE-DIABETES, DIABETES AND DIABETES RELATED CONDITIONS

IPC classification:
C12Q 1/68, C07K 14/47, A61K 38/17, C12Q 1/25, A61P 13/12, G01N 33/68
Applicant:
University of Western Australia
Agent:
William John Richards, Script IP Limited
Status:
APPLICATION REFUSED
EP11827879

HEAD MOUNTED LIGHT THERAPY DEVICE

IPC classification:
F21K 99/00, A61M 21/00, F21L 4/00, A61N 5/06
Agent:
William John Richards, Script IP Limited
Status:
GRANT OF PATENT INTENDED
EP12811348

METHOD AND DEVICE FOR CONFIGURING A COMMUNICATION SYSTEM

IPC classification:
H04W 84/16, H04M 3/42, H04L 29/02
Agent:
William John Richards, Script IP Limited
Agent:
HGF Limited
Status:
The patent has been granted
EP13164423

Mesenchymal stem cell conditioned medium

IPC classification:
C12N 5/071, A61K 35/28
Agent:
William John Richards, Script IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP12791643

MONOCLONAL ANTIBODIES AGAINST SEROTRANSFERRIN ANTIGENS, AND USES THEREFOR

IPC classification:
G01N 33/53, C07K 16/18
Agent:
William John Richards, Script IP Limited
Agent:
Leythem Wall, Finnegan Europe LLP
Status:
EXAMINATION IN PROGRESS
EP12809298

METHODS FOR DETECTING OF BENIGN CONDITIONS

IPC classification:
A61B 10/02, G01N 33/68, G01N 33/574, C12Q 1/04
Applicant:
Medical Research Council
Agent:
Candida Jane Soames, Maschio & Soames IP Limited
Agent:
William John Richards, Script IP Limited
Status:
The patent has been granted
EP12810647

METHOD, DEVICE AND SYSTEM FOR DETERMINING TOPOLOGY OF A WIRELESS COMMUNICATION NETWORK

IPC classification:
H04W 40/24, H04L 12/24, G01S 5/02
Agent:
William John Richards, Script IP Limited
Agent:
HGF Limited
Status:
PATENT GRANTED
EP11773804

METHODS FOR INCORPORATING UNNATURAL AMINO ACIDS IN EUKARYOTIC CELLS

IPC classification:
C12P 21/02, C12P 19/34, C12N 15/11, C12N 15/09
Applicant:
Medical Research Council
Applicant:
North Carolina State University
Agent:
William John Richards, Script IP Limited
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11853000

MONOCLONAL ANTIBODIES AGAINST ALPHA-ACTININ-4 ANTIGENS, AND USES THEREFOR

IPC classification:
C12P 21/08, C07K 16/18, G01N 33/567
Agent:
William John Richards, Script IP Limited
Agent:
Martin Douglas Hyden, Finnegan Europe LLP
Agent:
Multiple attorneys, Finnegan LLP
Status:
APPLICATION DEEMED TO BE WITHDRAWN
EP11824763

CANCER HEAT THERAPY-ENHANCING AGENT

IPC classification:
A61P 43/00, A61P 35/00, A61K 31/197
Applicant:
SBI Pharmaceuticals Co Ltd
Agent:
William John Richards, Script IP Limited
Status:
NO OPPOSITION FILED WITHIN TIMELIMIT
EP16194985

BIOMARKERS ASSOCIATED WITH PRE-DIABETES, DIABETES AND DIABETES RELATED CONDITIONS

IPC classification:
C12Q 1/68, C07K 14/47, A61K 38/17, C12Q 1/25, A61P 13/12, G01N 33/68
Applicant:
University of Western Australia
Agent:
William John Richards, Script IP Limited
Status:
The patent has been granted
EP17206254

METHODS FOR TREATMENT OF NEPHROTIC SYNDROME AND RELATED CONDITIONS

IPC classification:
A61P 17/00, A61P 3/00, A61P 3/10, A61K 38/17, A61K 38/16
Agent:
William John Richards, Script IP Limited
Status:
The application has been published

Please Sign in to use this feature